golden pharmaceutical, inc.

22 highland road
brentwood, new york 11717

NYS Entity Status
ACTIVE

NYS Filing Date
JULY 15, 2013

NYS DOS ID#
4431073

County
SUFFOLK

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC BUSINESS CORPORATION

Name History
2013 - GOLDEN PHARMACEUTICAL, INC.









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • A Drug Maker Spends Big in Washington to Make Itself Heard
    By JAY HANCOCK, ELIZABETH LUCAS and SYDNEY LUPKIN - Friday Jul 21, 2017

    Mallinckrodt’s spending on political donations and lobbying comes as the drug industry as a whole beefs up its Capitol Hill presence.

    Source: NYT > Home Page
  • Police Criticize Trump for Urging Officers Not to Be ‘Too Nice’ With Suspects
    By BRIAN M. ROSENTHAL - Saturday Jul 29, 2017

    Law enforcement officials condemned the president’s remarks as inappropriate and potentially dangerous. Police supporters said it was clearly intended as a joke.

    Source: NYT > Home Page
  • Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
    By Ben Fidler - Tuesday Sep 12, 2017

    Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]

    Source: Xconomy New York
  • Trump to Police: 'Don't Be Too Nice'
    Friday Jul 28, 2017

    President Donald Trump suggested police should take a rougher approach with people suspected of crimes, in remarks to law enforcement officials in Brentwood, N.Y., about combatting gang activity and illegal immigration. Photo: Getty

    Source: The Wall Street Journal: Worth It
  • Considering the Side Effects of Drugmakers’ Money-Back Guarantees
    By KATIE THOMAS and CHARLES ORNSTEIN - Monday Jul 10, 2017

    The Trump administration is considering encouraging lowering drug costs through outcome-based contracts, but there is little evidence the approach works.

    Source: NYT > Home Page
golden pharmaceutical inc brentwood ny